← Back to Search

Comprehensive Care for Patients at High Risk of Hospitalization (CCP Trial)

N/A
Waitlist Available
Led By David Meltzer, MD, PhD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Medicare recipients and were hospitalized at least one time in the past year
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up cumulative after enrollment up to 3 years
Awards & highlights

CCP Trial Summary

This trial proposes a new model of care in which high-risk patients are seen by a physician who coordinates their care in the hospital and clinic. The investigators estimate that this model will be economically viable and clinically valuable for the patient.

Who is the study for?
This trial is for Medicare recipients who have been hospitalized at least once in the past year and are considered high risk for future hospitalizations. The goal is to provide these patients with a dedicated physician who manages their care both during hospital stays and outpatient clinic visits.Check my eligibility
What is being tested?
The trial tests a new care model where high-risk patients receive integrated inpatient and outpatient services from the same physician, aiming to reduce hospitalizations and costs. Five physicians will each manage about 200 patients, focusing on continuity of care.See study design
What are the potential side effects?
Since this trial involves a new model of healthcare delivery rather than a medication or medical procedure, there aren't traditional side effects. However, changes in care coordination could impact patient satisfaction, access to care, or health outcomes.

CCP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

CCP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~cumulative after enrollment up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and cumulative after enrollment up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Satisfaction
Total Cost of Care
Secondary outcome measures
Care utilization
Doctor-patient relationship
Mortality
+1 more
Other outcome measures
Provider outcomes

CCP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Comprehensive CareExperimental Treatment1 Intervention
Patients randomized to the Comprehensive Care group are assigned to a Comprehensive Care physician and are asked to see their assigned CCP for their primary care. The patients will receive their care by the CCP in the outpatient clinic and also if they were to be hospitalized.
Group II: Standard of CareActive Control1 Intervention
If patients are randomized to standard of care, they are not assigned to a Comprehensive Care Physician. They are asked to continue receiving their care as they normally would.

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,012 Previous Clinical Trials
732,062 Total Patients Enrolled
University HealthSystem ConsortiumOTHER
1 Previous Clinical Trials
41 Total Patients Enrolled
University of Illinois at ChicagoOTHER
614 Previous Clinical Trials
1,560,343 Total Patients Enrolled

Media Library

Comprehensive Care Clinical Trial Eligibility Overview. Trial Name: NCT01929005 — N/A
Medicare Patients Research Study Groups: Standard of Care, Comprehensive Care
Medicare Patients Clinical Trial 2023: Comprehensive Care Highlights & Side Effects. Trial Name: NCT01929005 — N/A
Comprehensive Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT01929005 — N/A
~160 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top